Lir Life Sciences Corp. — Investor Relations & Filings
Filings indexed
141
across all filing types
Latest filing
2023-11-20
Regulatory Filings
Country
CA
Canada
Listing
CSE
SKNY
Lir Life Sciences Corp. is a biopharmaceutical company specializing in the development of next-generation therapies for obesity and metabolic disorders. The company's core focus is advancing treatment accessibility through innovative drug-delivery approaches, specifically developing transdermal and alternative GLP-1 solutions. These therapies are designed to be scalable, affordable, and accessible globally, aiming to reduce reliance on traditional injections. Lir Life Sciences targets regions with rising obesity rates and limited access to existing GLP-1 treatments, addressing a significant unmet need in the rapidly growing global market.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| News release - English.pdf | 2023-11-20 | English | |
| News release - English.PDF | 2023-10-27 | English | |
| News release - English.pdf | 2023-10-11 | English | |
| 52-109FV2 - Certification of interim filings - CEO (E).PDF | 2023-09-30 | English | |
| 52-109FV2 - Certification of interim filings - CFO (E).PDF | 2023-09-30 | English | |
| Interim MD&A - English.PDF | 2023-09-30 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2023
15 filings
| |||||
| 29495400 | News release - English.pdf | 2023-11-20 | English | ||
| 13700003 | News release - English.PDF | 2023-10-27 | English | ||
| 29335639 | News release - English.pdf | 2023-10-11 | English | ||
| 13695958 | 52-109FV2 - Certification of interim filings - CEO (E).PDF | 2023-09-30 | English | ||
| 13695957 | 52-109FV2 - Certification of interim filings - CFO (E).PDF | 2023-09-30 | English | ||
| 13695962 | Interim MD&A - English.PDF | 2023-09-30 | English | ||
| 13695964 | Interim financial statements/report – English.PDF | 2023-09-30 | English | ||
| 29256060 | News release - English.PDF | 2023-09-27 | English | ||
| 29256063 | News release - English.PDF | 2023-09-27 | English | ||
| 29256075 | News release - English.PDF | 2023-09-27 | English | ||
| 13691763 | News release - English.pdf | 2023-09-06 | English | ||
| 29060313 | Form of proxy - English.pdf | 2023-08-21 | English | ||
| 29060309 | Other.pdf | 2023-08-21 | English | ||
| 29060298 | Other.pdf | 2023-08-21 | English | ||
| 29060280 | Notice of meeting - English.pdf | 2023-08-21 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Lir Life Sciences Corp. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/48076/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=48076 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=48076 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=48076 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 48076}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Lir Life Sciences Corp. (id: 48076)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.